Posted inDiabetes & Endocrinology news
Diminished Arginine Bioavailability in A-β+ Ketosis-Prone Diabetes: A Distinct Metabolic Signature Underlying Ketoacidosis Risk
This study reveals that reduced arginine availability during hyperglycaemia distinguishes A-β+ ketosis-prone diabetes from type 2 diabetes, implicating impaired arginine metabolism in ketoacidosis pathogenesis and highlighting citrulline supplementation as a potential therapeutic strategy.
